Doxepin Tablet
Product Images NDC 59651-845

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Doxepin (NDC 59651-845). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (3 mg (30 Tablets Bottle))

This text is explaining the details of Doxepin Tablets, including the dosage information, pharmaceutical company, ingredients, storage conditions, and safety guidelines. It also mentions the need to dispense the Medication Guide provided to each patient. The tablets contain 3.39 mg of doxepin hydrochloride. The product is distributed by Aurobindo Pharma USA, Inc. from East Windsor, NJ. It further includes a recommended dosage, storage temperature, and information on how to print Medication Guides and necessary coding on the packaging.*

FDA Label Image

Package Label-principal Display Panel (6 mg (30 Tablets Bottle))

This description is about Doxepin Tablets with 6 mg strength. The tablets come in a pack of 30 and each tablet contains 6.78 mg of doxepin hydrochloride, USP, equivalent to 6 mg of doxepin. It is advised to keep the medication out of reach of children and store it at 20° to 25°C. The medication should be dispensed in a tight, light-resistant container with a child-resistant closure. The manufacturer is Aurobindo Pharma USA, Inc., and the medication guides can be found on their website. The product is made in India.*

FDA Label Image

Chemical Structure (Doxepin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.